Phillip Pang

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

VIR

Current role

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2023	Vir Biotechnology, Inc. (VIR)	M.D., Ph.D. Former Executive Vice President, Chief Medical Officer and Interim Head of Research Ann (Aine) Hanly, Ph.D. Executive Vice President and Chief Technology Officer	$527,000	—	$1,620,600	$1,533,616	$257,774	$13,200	$3,952,190
2022	Vir Biotechnology, Inc. (VIR)	M.D., Ph.D. Former Executive Vice President, Chief Medical Officer and Interim Head of Research Ann (Aine) Hanly, Ph.D. Executive Vice President and Chief Technology Officer	$507,400	$125,000	$1,975,160	$1,578,694	$192,780	$12,200	$4,391,234
2021	Vir Biotechnology, Inc. (VIR)	M.D., Ph.D. Former Executive Vice President, Chief Medical Officer and Interim Head of Research Ann (Aine) Hanly, Ph.D. Executive Vice President and Chief Technology Officer	$492,000	—	$2,156,160	$3,496,896	$276,864	$11,600	$6,433,520

No earnings-call appearances or filed executive changes recorded yet.